UBS Group’s Aptevo Therapeutics APVO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-39
| Closed | -$3.38K | – | 8868 |
|
|
2024
Q4 | $3.38K | Buy |
+39
| New | +$3.38K | ﹤0.01% | 7642 |
|
|
2024
Q3 | – | Sell |
-157
| Closed | -$35.5K | – | 8256 |
|
|
2024
Q2 | $35.5K | Buy |
+157
| New | +$35.5K | ﹤0.01% | 5809 |
|
|
2024
Q1 | – | Hold |
0
| – | -$1 | – | 8075 |
|
|
2023
Q4 | – | Hold |
0
| – | -$28 | – | 7982 |
|
|
2023
Q3 | – | Hold |
0
| – | – | – | 7939 |
|
|
2023
Q1 | – | Hold |
0
| – | -$3.32K | – | 8454 |
|
|
2022
Q4 | – | Hold |
0
| – | -$1K | – | 8328 |
|
|
2022
Q3 | – | Hold |
0
| – | -$4K | – | 8809 |
|
|
2022
Q2 | – | Hold |
0
| – | – | – | 7988 |
|
|
2022
Q1 | – | Hold |
0
| – | -$25K | – | 9128 |
|
|
2021
Q4 | – | Hold |
0
| – | – | – | 6464 |
|
|
2021
Q3 | – | Hold |
0
| – | -$41K | – | 8329 |
|
|
2021
Q2 | – | Hold |
0
| – | – | – | 5533 |
|
|
2021
Q1 | – | Hold |
0
| – | -$11K | – | 7895 |
|
|
2020
Q4 | – | Hold |
0
| – | -$67K | – | 6371 |
|
|
2020
Q3 | – | Hold |
0
| – | -$83K | – | 4594 |
|
|
2020
Q2 | – | Hold |
0
| – | -$43K | – | 4615 |
|
|
2020
Q1 | – | Hold |
0
| – | -$115K | – | 5058 |
|
|
2019
Q4 | – | Hold |
0
| – | -$81K | – | 4900 |
|
|
2019
Q3 | – | Hold |
0
| – | -$85K | – | 4965 |
|
|
2019
Q2 | – | Hold |
0
| – | -$43K | – | 4642 |
|
|
2019
Q1 | – | Hold |
0
| – | -$35K | – | 4844 |
|
|
2018
Q4 | – | Hold |
0
| – | -$193K | – | 5456 |
|
|
2018
Q3 | – | Hold |
0
| – | -$189K | – | 4259 |
|
|
2018
Q2 | – | Hold |
0
| – | -$149K | – | 4136 |
|
|
2018
Q1 | – | Hold |
0
| – | -$193K | – | 4158 |
|
|
2017
Q4 | – | Hold |
0
| – | -$20K | – | 4028 |
|
|
2017
Q3 | – | Hold |
0
| – | -$65K | – | 5545 |
|
|
2017
Q2 | – | Hold |
0
| – | -$62K | – | 4567 |
|
|
2017
Q1 | – | Hold |
0
| – | -$30K | – | 4475 |
|
|
2016
Q4 | – | Hold |
0
| – | -$28K | – | 5298 |
|
|
2016
Q3 | – | Hold |
0
| – | – | – | 5114 |
|